Objective: We evaluated the safety and efficacy of intra-articular (IA) magnesium (Mg) for postoperative pain relief after arthroscopic knee surgery.
Methods. We searched PubMed, Embase, Medline, Cochrane library, and Web of Science to identify randomized controlled trials that compared postoperative pain outcomes with or without IA Mg after knee arthroscopy. The primary outcomes were pain intensity at rest and with movement at different postoperative time points and cumulative opioid consumption within 24 hours after surgery. Secondary outcomes included the time to first analgesic request and side effects.
Results. In total, 11 randomized controlled trials involving 677 subjects met the eligibility criteria. Pain scores at rest and with movement 2, 4, 12, and 24 h after surgery were significantly lower, doses of supplementary opioid consumption were smaller, and the time to first analgesic requirement was longer in the IA Mg group compared with the control group. No significant difference was detected regarding adverse reactions between the groups.
Conclusions. Administering IA Mg following arthroscopic knee surgery is effective for relieving postoperative pain intensity, reducing opioid consumption, and prolonging the time before analgesics are needed without increasing adverse reactions.
Protocol registration at Prospero: CRD42020156403.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6
Loading...
On 23 Jan, 2021
On 19 Jan, 2021
On 19 Jan, 2021
On 19 Jan, 2021
Posted 17 Jan, 2021
Received 17 Jan, 2021
On 17 Jan, 2021
On 15 Jan, 2021
Received 15 Jan, 2021
On 13 Jan, 2021
Received 13 Jan, 2021
Invitations sent on 12 Jan, 2021
On 12 Jan, 2021
On 01 Jan, 2021
On 01 Jan, 2021
On 01 Jan, 2021
Posted 24 Nov, 2020
On 03 Dec, 2020
On 02 Dec, 2020
Received 02 Dec, 2020
Received 02 Dec, 2020
Received 02 Dec, 2020
On 29 Nov, 2020
Invitations sent on 28 Nov, 2020
On 28 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
On 23 Jan, 2021
On 19 Jan, 2021
On 19 Jan, 2021
On 19 Jan, 2021
Posted 17 Jan, 2021
Received 17 Jan, 2021
On 17 Jan, 2021
On 15 Jan, 2021
Received 15 Jan, 2021
On 13 Jan, 2021
Received 13 Jan, 2021
Invitations sent on 12 Jan, 2021
On 12 Jan, 2021
On 01 Jan, 2021
On 01 Jan, 2021
On 01 Jan, 2021
Posted 24 Nov, 2020
On 03 Dec, 2020
On 02 Dec, 2020
Received 02 Dec, 2020
Received 02 Dec, 2020
Received 02 Dec, 2020
On 29 Nov, 2020
Invitations sent on 28 Nov, 2020
On 28 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
On 18 Nov, 2020
Objective: We evaluated the safety and efficacy of intra-articular (IA) magnesium (Mg) for postoperative pain relief after arthroscopic knee surgery.
Methods. We searched PubMed, Embase, Medline, Cochrane library, and Web of Science to identify randomized controlled trials that compared postoperative pain outcomes with or without IA Mg after knee arthroscopy. The primary outcomes were pain intensity at rest and with movement at different postoperative time points and cumulative opioid consumption within 24 hours after surgery. Secondary outcomes included the time to first analgesic request and side effects.
Results. In total, 11 randomized controlled trials involving 677 subjects met the eligibility criteria. Pain scores at rest and with movement 2, 4, 12, and 24 h after surgery were significantly lower, doses of supplementary opioid consumption were smaller, and the time to first analgesic requirement was longer in the IA Mg group compared with the control group. No significant difference was detected regarding adverse reactions between the groups.
Conclusions. Administering IA Mg following arthroscopic knee surgery is effective for relieving postoperative pain intensity, reducing opioid consumption, and prolonging the time before analgesics are needed without increasing adverse reactions.
Protocol registration at Prospero: CRD42020156403.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6
Loading...